x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

65 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

GERMANIA

Hessen
FRANKFURT AM MAIN

REGNO UNITO; GRAN BRETAGNA

Tayside
DUNDEE

Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
University of Dundee
Division of Molecular Medicine

FRANCIA

ILE-DE-FRANCE
PARIS

VPACS : Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment
Hôpital Necker-Enfants Malades
Service de Réanimation et unités de soins continus médico-chirurgicale pédiatriques

FRANCIA

OCCITANIE
TOULOUSE

OTBB : Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies and Effect on Suck and Food Intake (Phase I-II)
CHU de Toulouse - Hôpital des Enfants
Centre de référence du syndrome de Prader-Willi

FRANCIA

OCCITANIE
TOULOUSE

OTBB2 : Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants (Phase I-II)
CHU de Toulouse - Hôpital des Enfants
Centre de référence du syndrome de Prader-Willi

FRANCIA

OCCITANIE
TOULOUSE

PRADOTIM : Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome (Phase II-III)
CHU de Toulouse - Hôpital des Enfants
Centre de référence du syndrome de Prader-Willi

FRANCIA

OUTRE-MER
FORT DE FRANCE

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) (Phase III)
CHU de Martinique - Hôpital P. Zobda-Quitman
Cardiologie Pédiatrique et Congénitale

PAESI BASSI

Noord-Holland
AMSTERDAM

Sperimentazione in corso
Microvascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REGNO UNITO; GRAN BRETAGNA

Merseyside
LIVERPOOL

Sperimentazione in corso
Effects of exenatide on appetite and ghrelin levels in patients with Prader-Willi Syndrome
Fazakerley Hospital
University Hospital Aintree - Diabetes and Endocrinology

REGNO UNITO; GRAN BRETAGNA

West Midlands
BIRMINGHAM

SPAGNA

Madrid
MADRID

Sperimentazione in corso
Setmelanotide (RM-493): Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Endocrinología, Crecimiento y Metabolismo

Sperimentazioni cliniche internazionali